Conference Coverage

ISET 2017

February 04, 2017

February 08, 2017

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Though lessons can be learned from the coronary territory, BRS in development for use in the peripherals face unique challenges.

News

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

News Conference News ISET 2017

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

Caitlin E. Cox

February 13, 2017

News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox

February 10, 2017

News Conference News ISET 2017

Patient Follow-up After Pulmonary Embolism Critical for Better Care, Understanding of Disease

Caitlin E. Cox

February 08, 2017

Slides

Presentation ISET 2017

Current Challenges in the Diagnosis and Treatment of CLI

Presenter: Alik Farber

February 06, 2017

Presentation ISET 2017

Update on the CREST 2 Trial

Presenter: Thomas G. Brott

February 06, 2017

Presentation ISET 2017

TAVR: What are the Limits Today and Where are We Going in the Future?

Presenter: Ron Waksman

February 05, 2017

Presentation ISET 2017

CTEPH: Who is at Risk, and How to Avoid

Presenter: Victor F Tapson

February 04, 2017

Presentation ISET 2017

Anticoagulation Following DVT: Agents and Length of Treatment

Presenter: Ian del Conde

February 04, 2017

All Conference Content

Advertisement

ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

News

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Gains in Carotid Stenting Technology Could Increase the Treatment’s Appeal

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Patient Follow-up After Pulmonary Embolism Critical for Better Care, Understanding of Disease

Slides

Current Challenges in the Diagnosis and Treatment of CLI

Update on the CREST 2 Trial

TAVR: What are the Limits Today and Where are We Going in the Future?

CTEPH: Who is at Risk, and How to Avoid

Anticoagulation Following DVT: Agents and Length of Treatment

@TCTMD

Advertisement

All Conference Content

Advertisement

ISET 2017

News

Slides

Advertisement

All Conference Content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

ISET 2017